Ajax-Loading

AstraZeneca PLC - Financial Leverage Ratio

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Financial-Leverage-Ratio" stands at 2.54 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of AstraZeneca PLC's third quarter, the item "Financial Leverage Ratio" stands at 2.54. This represents a decrease of -0.84 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.66 percent compared to the value the year prior.
The 1 year change in percent is -3.66.
The 3 year change in percent is -6.19.

The Serie's long term average value is 2.65. It's latest available value, on 09/30/2025, is 4.37 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -14.05%.

Financial Leverage Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Financial Leverage Ratio905,699,262,464.00
LogoJohnson & Johnson - Financial Leverage Ratio486,508,953,600.00
LogoAbbVie Inc - Financial Leverage Ratio399,570,305,024.00
LogoRoche Holding AG - Financial Leverage Ratio317,433,206,677.55
LogoNovartis AG - Financial Leverage Ratio255,096,620,580.91